Referred to the Subcommittee on Health.
This resolution is a nonbinding statement from Congress urging increased Federal funding for juvenile (Type 1) diabetes research in line with the Diabetes Research Working Group recommendations. It expresses lawmakers' view and priorities but does not change any law, create or authorize spending, or require agencies to act. If both chambers adopt it, it signals congressional intent but has no legal force.
Concurrent resolutions must be passed by both the House and the Senate but are not presented to the President and do not have the force of law.
This nonbinding House concurrent resolution urges increased Federal funding for juvenile (Type 1) diabetes research.
It cites prevalence statistics, cites a Diabetes Research Working Group recommendation (about $1.6 billion in 2004), notes then-current NIH funding ($946 million), and encourages funding increases consistent with those recommendations to pursue a cure.
Concurrent resolution expresses policy preference and does not create law; it cannot become law even if adopted by both chambers.
Relative to its intended legislative type, this bill is a clear, well-focused expression of congressional sentiment. It documents the problem and cites a specific funding gap and advisory recommendation, but, as a nonbinding resolution, it appropriately omits implementation, appropriation, and oversight mechanisms.
Amount and pace of new federal funding
These are examples from the analysis, not a ranked list of the most-affected groups.
Amount and pace of new federal funding
Likely strongly supportive.
The resolution calls for more federal investment in a serious childhood disease, aligning with priorities for public health research and equity.
It also highlights public-private partnership and specific funding shortfalls.
Generally favorable but pragmatic.
Supports more research funding for a major disease but wants clear budgets, oversight, and evidence that spending yields results.
Prefers phased, accountable increases tied to outcomes.
Cautious to mixed.
Supports research into childhood diseases in principle but wary of expanding federal spending.
Prefers private-sector leadership, efficiency, and strict accountability before increasing appropriations.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Concurrent resolution expresses policy preference and does not create law; it cannot become law even if adopted by both chambers.
The bill has not accumulated any surfaced votes yet.
Amount and pace of new federal funding
Concurrent resolution expresses policy preference and does not create law; it cannot become law even if adopted by both chambers.
Relative to its intended legislative type, this bill is a clear, well-focused expression of congressional sentiment. It documents the problem and cites a specific funding gap and advisory recommendation, but, as a nonbi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.